Showing results (721-730 of 747) with videos related to
Sort By:
Pageof 75
Neurology|March 7, 2008
Safety and efficacy of galantamine in subjects with mild cognitive impairmentB Winblad, S Gauthier, L Scinto, et al.Dementia and Geriatric Cognitive Disorders|June 5, 2003
Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairmentD Religa, M Styczynska, B Peplonska, et al.Archives of Neurology|December 26, 2001
Current concepts in mild cognitive impairmentR C Petersen, R Doody, A Kurz, et al.Journal of Internal Medicine|September 29, 2018
Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementiaB Petek, M Villa-Lopez, R Loera-Valencia, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilitiesA Nordberg, K Amberla, M Shigeta, et al.Journal of Cellular and Molecular Medicine|January 23, 2008
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathologyR Liu, X-W Zhou, H Tanila, et al.The American Journal of Pathology|April 1, 1996
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein geneD M Mann, T Iwatsubo, Y Ihara, et al.Forensic Science International|December 17, 1998
Alzheimer changes are common in aged drivers killed in single car crashes and at intersectionsM Viitanen, K Johansson, N Bogdanovic, et al.Neuroscience Letters|January 28, 2012
Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanismsA Besga, A Cedazo-Minguez, I Kåreholt, et al.Neurobiology of Aging|January 1, 1997
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brainsT Pirttilä, H Soininen, P D Mehta, et al.Pageof 75